Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients.
Nelson DR, Zeuzem S, Andreone P, Ferenci P, Herring R, Jensen DM, Marcellin P, Pockros PJ, Rodríguez-Torres M, Rossaro L, Rustgi VK, Sepe T, Sulkowski M, Thomason IR, Yoshida EM, Chan A, Hill G.
Nelson DR, et al. Among authors: hill g.
Ann Hepatol. 2012 Jan-Feb;11(1):15-31.
Ann Hepatol. 2012.
PMID: 22166557
Free PMC article.
Clinical Trial.